03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Clinician · Rare diseases
Nathaniel Miller: no photograph is held, so the clinician plate is shown instead.
Clinician
Nathaniel Miller
M.D., Mayo Clinic family medicine physician and first author of the study
1
Nov 2026to date
1
press citation on 1 topic since 2 Nov 2026 · last quoted 2 Nov 2026
02 Quoted on · 1 of 29 topics
Nathaniel Miller: key facts
- Kind of voice
- Clinician
- Role
- M.D., Mayo Clinic family medicine physician and first author of the study
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 2 Nov 2026
04 The signal · where Nathaniel Miller sits on rare diseases
Ranked 49= of 100 voices quoted in the press on rare diseases, level with 51 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)9
- 2Dr Harrison CarterAcademicDirector of Screening at NHS England8
- 3=
Prof Dame Sue HillRegulatorChief Scientific Officer for England and Senior Responsible Officer for Genomics, NHS England7 - 49=Jacqueline SheaAcademicPh.D., CEO of Inovio1
- 49=Michael SumnerSector leaderChief Medical Officer, Inovio1
- 49=Nathaniel MillerClinicianM.D., Mayo Clinic family medicine physician and first author of the study1
- 49=Frederick KaplanAcademicProfessor of molecular orthopedics, University of Pennsylvania Perelman School of Medicine1
- 49=Sabina BerrettaClinicianco-senior author and associate professor of psychiatry at Harvard Medical School and McLean Hospital1
Showing the leaders and the ranks around 49=, of 100 voices · See every voice on the topic →
05 On the record · press
What Nathaniel Miller has said
By outlet · linked articles
- technologynetworks.com1
Where Nathaniel Miller has been quoted
- 01Genetic Testing May Identify Carriers of Inherited Blood Disorderstechnologynetworks.com · 2 Nov 2026
Verbatim
“If we can identify carrier status earlier, we have more opportunities for reproductive counseling, appropriate preventive care and helping patients understand what these findings may mean for their families”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Coventry tot's heartbreaking health battle after 'extremely rare' diagnosiscoventrytelegraph.net
- Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdlereuters.com
- 'Immoral lottery' - Mum's plea after losing daughter to rare diseasethewestmorlandgazette.co.uk
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.